Impact of Shenmai Injection Combined with Chemotherapy on T-cell Subsets and Cytokine Profiles in Patients with Advanced Non-Small Cell Lung Cancer.

医学 肺癌 化疗 细胞因子 细胞 肿瘤科 癌症 内科学 生物 遗传学
作者
Jianping Jiang,Weiqiang Mo,Xue Lian,Xiaoyan Jin,Haiying Cheng
出处
期刊:PubMed [National Institutes of Health]
链接
标识
摘要

Background: Non-small cell lung cancer (NSCLC) represents a significant portion of lung cancer cases, with a poor prognosis and limited treatment options for advanced stages. Enhancing the effectiveness of chemotherapy through adjunctive therapies is a critical area of research. Objective: To evaluate the effect of Shenmai injection combined with chemotherapy on T-cell subsets and cytokine expression in patients with advanced NSCLC. Methods: A comparative prospective study was conducted, and a total of 96 patients with advanced NSCLC were selected. Patients were divided into two groups based on different chemotherapy regimens: an observation group (48 patients) receiving Shenmai injection combined with chemotherapy and a control group (48 patients) receiving chemotherapy alone. The study measures and compares the levels of T-cell subsets (CD3+, CD4+, CD4+/CD8+) and cytokines (IL-2, IL-4, IL-5, IL-6, TNF-α, IFN-γ, VEGF, bFGF, CA125, and CEA) before and after treatment in both groups. Statistical analysis was performed on the collected data. Results: Significant changes were observed in the levels of T-cell subsets and cytokines before and after chemotherapy in both groups (P < .05). Compared with the control group, the observation group exhibited significant improvement in T-cell subsets CD3+, CD4+, and CD4+/CD8+ (P < .05). Furthermore, the levels of cytokines IL-2, IL-4, IL-5, IL-6, TNF-α, IFN-γ, VEGF, bFGF, CA125, and CEA were significantly lower in the observation group compared to the control group (all P < .05). Conclusions: Shenmai injection combined with chemotherapy enhances the cellular immune function in patients with advanced NSCLC. This combination therapy not only reverses tumor progression but also improves the overall therapeutic effect, suggesting a promising adjunctive treatment strategy for advanced NSCLC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
傻子发布了新的文献求助20
1秒前
1秒前
1秒前
Twinkle发布了新的文献求助10
2秒前
SciGPT的应助被威武的皮卡丘采纳,获得10
2秒前
秋风的应助被Linkkk采纳,获得10
2秒前
3秒前
完美世界的应助被科研通管家采纳,获得10
3秒前
yang完成签到 ,获得积分10
3秒前
CarryLJR的应助被科研通管家采纳,获得10
3秒前
3秒前
Hello的应助被科研通管家采纳,获得10
3秒前
DW的应助被科研通管家采纳,获得10
3秒前
酷波er的应助被科研通管家采纳,获得10
3秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
3秒前
今后的应助被科研通管家采纳,获得10
3秒前
n01W97的应助被科研通管家采纳,获得20
4秒前
4秒前
Maestro_S的应助被科研通管家采纳,获得10
4秒前
传奇3的应助被科研通管家采纳,获得10
4秒前
江就的应助被科研通管家采纳,获得10
4秒前
4秒前
李爱国的应助被科研通管家采纳,获得10
4秒前
4秒前
4秒前
我是老大的应助被科研通管家采纳,获得10
4秒前
科目三的应助被科研通管家采纳,获得10
4秒前
传奇3的应助被科研通管家采纳,获得10
5秒前
5秒前
6秒前
MAX发布了新的文献求助10
6秒前
6秒前
LiuShenglan发布了新的文献求助10
6秒前
7秒前
qaplay发布了新的文献求助10
7秒前
duojiala完成签到,获得积分10
7秒前
领导范儿的应助被什玖采纳,获得10
8秒前
超级无敌的应助被方俊驰采纳,获得10
8秒前
shine发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189382
求助须知:如何正确求助?哪些是违规求助? 9576691
关于积分的说明 21849410
捐赠科研通 7787318
什么是DOI,文献DOI怎么找? 3435538
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509